Please assess the completion status of the following clinical trial:

Trial Title: Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Diagnosis of advanced hepatobiliary carcinoma not amenable to conventional surgery~  * Gall bladder carcinoma~ * Cholangiocarcinoma~ * Carcinoma of the ampulla~ * Hepatocellular carcinoma (eligible for cohort II only)~* Measurable disease~* No known brain metastases~PATIENT CHARACTERISTICS:~Age:~* 18 and over~Performance status:~* ECOG 0-2~Life expectancy:~* At least 12 weeks~Hematopoietic:~* WBC at least 3,000/mm\^3~* Granulocyte count at least 1,500/mm\^3~* Platelet count at least 100,000/mm\^3~* Hemoglobin greater than 10 g/dL~Hepatic:~* Bilirubin less than 3 mg/dL~  * Cohort I (closed to accrual as of 11/1/03)~    * Bilirubin no greater than 1.5 mg/dL~   * AST no greater than 2.5 times upper limit of normal (ULN)~ * Cohort II~    * Bilirubin greater than 1.5 mg/dL and less than 3 mg/dL OR~   * Bilirubin no greater 1.5 mg/dL AND AST greater than 2.5 times ULN~Renal:~* Creatinine normal OR~* Creatinine clearance at least 60 mL/min~Cardiovascular:~* No New York Heart Association class III or IV heart disease~Other:~* Not pregnant or nursing~* Negative pregnancy test~* Fertile patients must use effective contraception~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Not specified~Chemotherapy:~* No prior chemotherapy for cholangiocarcinoma or hepatobiliary carcinoma~Endocrine therapy:~* Not specified~Radiotherapy:~* Not specified~Surgery:~* Not specified~Other:~* No concurrent combination antiviral therapy for HIV-positive patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).